The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of elevated ctDNA burden following one cycle of chemotherapy with inferior outcomes for patients with metastatic Ewing sarcoma: A report from the Children’s Oncology Group (COG).
 
David Stephen Shulman
Consulting or Advisory Role - Boehringer Ingelheim
 
Kelly S. Klega
No Relationships to Disclose
 
Allen Buxton
No Relationships to Disclose
 
Mohammad Tanhaemami
No Relationships to Disclose
 
Jessica Armstrong
No Relationships to Disclose
 
Carrie Cibulskis
No Relationships to Disclose
 
Richard Greg Gorlick
Consulting or Advisory Role - Abbvie; Jazz Pharmaceuticals
Research Funding - Eisai (Inst); HebeCell (Inst); Repare Therapeutics (Inst)
 
Julia Lynne Glade Bender
Consulting or Advisory Role - Jazz Pharmaceuticals
Research Funding - Bayer (Inst); Eisai (Inst); Jazz Pharmaceuticals (Inst); Jazz Pharmaceuticals (Inst); Lilly (Inst); Loxo (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Patent on a T lympboblastic lymphoma cell line, CUTLL1
Travel, Accommodations, Expenses - Amgen (Inst); Eisai (Inst)
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb; Eisai; Merck; Pfizer; SpringWorks Therapeutics
 
Damon R. Reed
Consulting or Advisory Role - Eisai; SpringWorks Therapeutics
 
Katherine A. Janeway
Honoraria - Foundation Medicine; Takeda
Consulting or Advisory Role - Bayer; Bayer; Illumina; Ipsen
Travel, Accommodations, Expenses - Bayer
 
Steven G. DuBois
Consulting or Advisory Role - Amgen; Bayer; InhibRx; Jazz Pharmaceuticals
Research Funding - Bayer (Inst); BMS (Inst); Curis (Inst); Eisai (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Salarius Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc
 
Brian D. Crompton
Employment - Acceleron Pharma (I); Generate Biomedicines (I)
Leadership - New Age Industries (I)
Stock and Other Ownership Interests - Acceleron Pharma (I)
Consulting or Advisory Role - Animal Cancer Foundation; AstraZeneca; PetDx
Research Funding - Gradalis